170 NMS-E628, a potent and orally available small molecule inhibitor of anaplastic lymphoma kinase, reduces tumor growth in an intracranial model of ALK-dependent NSCLC

✍ Scribed by E. Ardini; M. Menichincheri; P. Magnaghi; C. De Ponti; N. Amboldi; A. Degrassi; M. Russo; P. Orsini; E. Pesenti; A. Galvani

• Book ID: 119602851
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 46 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)71875-9